Amlodipine and Olmesartan Medoxomil
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-448 -
Package NDC
31722-448-30 -
Package NDC
31722-448-90 -
Application number
ANDA209591 -
SPL ID
313d90a7-6e92-d956-e063-6394a90a3d6e -
SPL set ID
99865c67-5475-4e60-98d5-a8fa850fe9ba -
UNII
864V2Q084H -
UNII
6M97XTV3HD -
RxCUI
730861 -
RxCUI
730866 -
RxCUI
730869 -
RxCUI
730872
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- Amlodipine and Olmesartan Medoxomil
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Amlodipine and Olmesartan Medoxomil",
"splId": "313d90a7-6e92-d956-e063-6394a90a3d6e",
"labels": [
{
"setId": "99865c67-5475-4e60-98d5-a8fa850fe9ba",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99865c67-5475-4e60-98d5-a8fa850fe9ba",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99865c67-5475-4e60-98d5-a8fa850fe9ba"
}
],
"routes": [
"ORAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-448-30)",
"package_ndc": "31722-448-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250214"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (31722-448-90)",
"package_ndc": "31722-448-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20250214"
}
],
"productId": "31722-448_313d90a7-6e92-d956-e063-6394a90a3d6e",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "31722-448",
"deaSchedule": null,
"genericName": "Amlodipine and Olmesartan Medoxomil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMLODIPINE BESYLATE",
"strength": "10 mg/1"
},
{
"name": "OLMESARTAN MEDOXOMIL",
"strength": "40 mg/1"
}
],
"applicationNumber": "ANDA209591",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250214",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0331722448307",
"0331722447300",
"0331722445306",
"0331722446303"
],
"unii": [
"864V2Q084H",
"6M97XTV3HD"
],
"rxcui": [
"730861",
"730866",
"730869",
"730872"
],
"spl_set_id": [
"99865c67-5475-4e60-98d5-a8fa850fe9ba"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-448_313d90a7-6e92-d956-e063-6394a90a3d6e"